Dados B3 › EUCA4 × RADL3
EUCA4 × RADL3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | EUCA4 | RADL3 | year |
|---|---|---|---|
| ROE | 12.0% | 18.9% | 2025 |
| ROIC | 11.6% | 24.8% | 2025 |
| ROA | 6.7% | 5.5% | 2025 |
| Gross margin | 37.2% | 29.3% | 2025 |
| EBIT margin | 16.9% | 6.2% | 2025 |
| Net margin | 10.3% | 2.9% | 2025 |
| Net debt/EBITDA | 0.70x | 0.69x | 2025 |
| Current ratio | 2.32x | 1.46x | 2025 |
| Revenue growth (1y) | 8.6% | 13.8% | 2025 |
| Revenue growth (5y CAGR) | 11.5% | 17.1% | 2025 |
| Piotroski F-Score | 7/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | EUCA4 | RADL3 | year |
|---|---|---|---|
| P/E | 5.65x | 32.24x | 2025 |
| P/B | 0.65x | 5.71x | 2025 |
| EV/EBITDA | 2.87x | 9.37x | 2025 |
| FCF yield | 18.9% | 2.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:20 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:20 UTC. If this does not match /saude, you are reading a cached copy.